Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 486-492

  Park, Jeong Yeol ^a   Kim, Eyu Nyong ^a   Kim, Dae Yeon ^a   Suh, Dae Shik ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Young Tak ^a   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Lymph node; MRI; PET CT; Preoperative evaluation; Uterine corpus cancer

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KOREA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALIDITY; PREOPERATIVE CARE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

EID: 39249084861     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.044     Document Type: Article

References (20)

1. International Federation of Gynecology and Obstetecis. Corpus cancer staging. Int J Gynaecol Obstet 28 (1989) 190
2. Connor J.P., Andrews J.I., Anderson B., and Buller R.E. Computed tomography in endometrial carcinoma. Obstet Gynecol 95 (2000) 692-696
3. Hricak H., Rubinstein L.V., Gherman G.M., and Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 179 (1991) 829-832
4. Lai C.H., Yen T.C., and Chang T.C. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 19 (2007) 37-41
5. Schoder H., Erdi Y.E., Larson S.M., and Yeung H.W. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 30 (2003) 1419-1437
6. Wahl R.L. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 45 Suppl 1 (2004) 82S-95S
7. Juweid M.E., and Cheson B.D. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354 (2006) 496-507
8. Wahl R.L., Hutchins G.D., Buchsbaum D.J., Liebert M., Grossman H.B., and Fisher S. 18F-2-deoxy-2-fluoro-d-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 67 (1991) 1544-1550
9. Cachin F., Prince H.M., Hogg A., Ware R.E., and Hicks R.J. Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy. J Clin Oncol 24 (2006) 3026-3031
10. Warburg O. The metabolism of tumors (1930), Arnold Constable, London 75-327
11. Belhocine T., De Barsy C., Hustinx R., and Willems-Foidart J. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29 (2002) 1132-1139
12. Saga T., Higashi T., Ishimori T., Mamede M., Nakamoto Y., Mukai T., et al. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 17 (2003) 197-203
13. Umesaki N., Tanaka T., Miyama M., Kawamura N., Ogita S., Kawabe J., et al. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 80 (2001) 372-377
14. Lerman H., Metser U., Grisaru D., Fishman A., Lievshitz G., and Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 45 (2004) 266-271
15. Torizuka T., Kanno T., Futatsubashi M., Okada H., Yoshikawa E., Nakamura F., et al. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET. J Nucl Med 44 (2003) 1051-1056
16. Chao A., Chang T.C., Ng K.K., Hsueh S., Huang H.J., Chou H.H., et al. 18F-FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 33 (2006) 36-44
17. Horowitz N.S., Dehdashti F., Herzog T.J., Rader J.S., Powell M.A., Gibb R.K., et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 95 (2004) 546-551
18. Suzuki R., Miyagi E., Takahashi N., et al. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer 2 (Mar 2007) [Electronic publication ahead of print]
19. Sironi S., Picchio M., Landoni C., Galimberti S., Signorelli M., Bettinardi V., et al. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 34 (2007) 472-479
20. Mulder W.J., Griffioen A.W., Strijkers G.J., Cormode D.P., Nicolay K., and Fayad Z.A. Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomed 3 (2007) 307-324